应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
NVO 诺和诺德
盘后交易 08-24 17:54:01 EDT
46.92
+0.18
+0.39%
盘后
46.97
+0.05
+0.11%
17:53 EDT
最高
47.30
最低
46.57
成交量
965.50万
今开
47.09
昨收
46.74
日振幅
1.57%
总市值
2,075亿
流通市值
1,496亿
总股本
44.23亿
成交额
4.53亿
换手率
0.30%
流通股本
31.88亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
异动解读｜诺和诺德盘中上涨3.02%，启动低剂量口服减肥药临床试验
行情直击 · 08-19
异动解读｜诺和诺德盘中上涨3.02%，启动低剂量口服减肥药临床试验
据报诺和诺德（NVO）启动低剂量减肥药试验
金吾财讯 · 08-19
据报诺和诺德（NVO）启动低剂量减肥药试验
诺和诺德(NVO.US)启动低剂量Wegovy口服药临床研究 瞄准更广泛减重人群
智通财经 · 08-19
诺和诺德(NVO.US)启动低剂量Wegovy口服药临床研究 瞄准更广泛减重人群
据媒体消息，诺和诺德(NVO.US)在一项新的肥胖症研究中，开始测试低剂量Wegovy口服药片。
格隆汇 · 08-19
据媒体消息，诺和诺德(NVO.US)在一项新的肥胖症研究中，开始测试低剂量Wegovy口服药片。
美股异动｜减肥药概念股逆势上扬，礼来涨2.6%
格隆汇 · 08-18
美股异动｜减肥药概念股逆势上扬，礼来涨2.6%
异动解读｜诺和诺德盘中下跌3.05%，贝伦贝格下调评级至持有并降目标价
行情直击 · 08-12
异动解读｜诺和诺德盘中下跌3.05%，贝伦贝格下调评级至持有并降目标价
贝伦贝格降诺和诺德评级至“持有”
格隆汇 · 08-12
贝伦贝格降诺和诺德评级至“持有”
异动解读｜诺和诺德盘前下跌3.05%，贝伦贝格下调目标价至47美元
行情直击 · 08-12
异动解读｜诺和诺德盘前下跌3.05%，贝伦贝格下调目标价至47美元
贝伦贝格将诺和诺德目标股价从50美元下调至47美元。
智通财经 · 08-12
贝伦贝格将诺和诺德目标股价从50美元下调至47美元。
礼来减重药片打响全球争夺战：Foundayo率先在欧洲获批
环球市场播报 · 08-11
礼来减重药片打响全球争夺战：Foundayo率先在欧洲获批
礼来替尔泊肽狂飙：上半年销售277亿美元，GLP-1赛道格局重塑
蓝鲸财经 · 08-11
礼来替尔泊肽狂飙：上半年销售277亿美元，GLP-1赛道格局重塑
诺和诺德与亚马逊AWS建立战略合作伙伴关系 推动通过人工智能加速药物研发
格隆汇 · 08-10
诺和诺德与亚马逊AWS建立战略合作伙伴关系 推动通过人工智能加速药物研发
亚马逊公司：诺和诺德选定 AWS 作为合作伙伴。
智通财经 · 08-10
亚马逊公司：诺和诺德选定 AWS 作为合作伙伴。
诺和诺德(NVO.US)：各方人士在伦敦共同打造了一个创新中心。该合作将利用人工智能作为诺和诺德的创新驱动力。
智通财经 · 08-10
诺和诺德(NVO.US)：各方人士在伦敦共同打造了一个创新中心。该合作将利用人工智能作为诺和诺德的创新驱动力。
伯恩斯坦将诺和诺德目标价从200丹麦克朗上调至203丹麦克朗。
智通财经 · 08-10
伯恩斯坦将诺和诺德目标价从200丹麦克朗上调至203丹麦克朗。
Scholar Rock 因FDA质控警告，将诺和诺德工厂从药物申请中剔除
投资观察 · 08-08
Scholar Rock 因FDA质控警告，将诺和诺德工厂从药物申请中剔除
异动解读｜诺和诺德盘中上涨3.15%，Q2财报超预期叠加荷兰专利胜诉持续提振市场情绪
行情直击 · 08-07
异动解读｜诺和诺德盘中上涨3.15%，Q2财报超预期叠加荷兰专利胜诉持续提振市场情绪
异动解读｜诺和诺德盘前上涨3.09%，Q2财报超预期叠加荷兰专利胜诉持续提振市场情绪
行情直击 · 08-07
异动解读｜诺和诺德盘前上涨3.09%，Q2财报超预期叠加荷兰专利胜诉持续提振市场情绪
丹麦制药商诺和诺德、西兰制药早盘交易上涨3%至4%。
智通财经 · 08-07
丹麦制药商诺和诺德、西兰制药早盘交易上涨3%至4%。
异动解读｜诺和诺德盘中上涨3.02%，Q2财报超预期叠加荷兰专利胜诉持续提振市场情绪
行情直击 · 08-07
异动解读｜诺和诺德盘中上涨3.02%，Q2财报超预期叠加荷兰专利胜诉持续提振市场情绪
暂无数据
公司概况
公司名称：
诺和诺德
所属市场：
NYSE
上市日期：
--
主营业务：
Novo Nordisk A/S成立于1989年，由两家丹麦公司Nordisk Gentofte A/S和Novo Industri A/S合并而成。该公司是一家全球性的医疗保健公司，也是肥胖和糖尿病护理、制造和营销包括GLP-1受体激动剂和现代胰岛素在内的医药产品的世界领先企业。总部位于丹麦，业务遍及约80个国家，产品销往约170个国家。
发行价格：
--
{"stockData":{"symbol":"NVO","market":"US","secType":"STK","nameCN":"诺和诺德","latestPrice":46.92,"timestamp":1787601600000,"preClose":46.74,"halted":0,"volume":9655013,"hourTrading":{"tag":"盘后","latestPrice":46.9697,"preClose":46.92,"latestTime":"17:53 EDT","volume":124571,"amount":5844367.430304999,"timestamp":1787608407524,"change":0.0497,"changeRate":0.001059,"amplitude":0.003197},"delay":0,"changeRate":0.003851091142490366,"floatShares":3187922885,"shares":4423075124,"eps":4.003044,"marketStatus":"盘后交易","change":0.18,"latestTime":"08-24 17:54:01 EDT","open":47.09,"high":47.3,"low":46.565,"amount":452621023.33194,"amplitude":0.015725,"askPrice":47,"askSize":100,"bidPrice":46.88,"bidSize":3,"shortable":3,"etf":0,"ttmEps":4.003044,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":1,"adrRate":1,"listingDate":363499200000,"exchange":"NYSE","adjPreClose":46.74,"dividendRate":0.036699,"preHourTrading":{"tag":"盘前","latestPrice":47.09,"preClose":46.74,"latestTime":"09:29 EDT","volume":194753,"amount":9197718.340823999,"timestamp":1787578199999,"change":0.35,"changeRate":0.007488,"amplitude":0.012623},"postHourTrading":{"tag":"盘后","latestPrice":46.9697,"preClose":46.92,"latestTime":"17:53 EDT","volume":124571,"amount":5844367.430304999,"timestamp":1787608407524,"change":0.0497,"changeRate":0.001059,"amplitude":0.003197},"volumeRatio":0.722571,"optionData":{"bulkOrders":[{"symbol":"NVO","call":true,"expireDate":1844740800000,"strike":"75.0","timestamp":1787597598962,"price":3.55,"volume":2200,"amount":781000,"type":"-"}]},"impliedVol":0.349,"impliedVolPercentile":0.0478},"requestUrl":"/m/hq/s/NVO/tweets","defaultTab":"tweets","newsList":[{"id":"1136022135","title":"异动解读｜诺和诺德盘中上涨3.02%，启动低剂量口服减肥药临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1136022135","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136022135?lang=zh_cn&edition=full","pubTime":"2026-08-19 22:09","pubTimestamp":1787148581,"startTime":"0","endTime":"0","summary":"8月19日，诺和诺德盘中上涨3.02%，报47.02美元/股，成交额2.1亿美元。消息面上，诺和诺德已于8月12日正式启动一项名为OASIS 5的临床研究，旨在评估口服索玛鲁肽低剂量方案对超重或肥胖患者体重的影响。该研究计划纳入约450名受试者，预计于2028年4月完成，主要终点为确定口服索玛鲁肽治疗超重或肥胖患者的最低有效剂量。此举被视为诺和诺德在口服GLP-1赛道上的进一步布局。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660418064","title":"据报诺和诺德（NVO）启动低剂量减肥药试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2660418064","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660418064?lang=zh_cn&edition=full","pubTime":"2026-08-19 17:38","pubTimestamp":1787132322,"startTime":"0","endTime":"0","summary":"根据美国政府临床试验数据库最新发布的信息，诺和诺德已于8月12日正式启动一项涵盖450名患者的全新临床研究，旨在评估其热门减肥药索玛鲁肽口服制剂的低剂量疗效。随着减重市场的成熟，诺和诺德希望通过该研究确定在帮助患者维持或达成减重目标的前提下，可使用的最低有效剂量，从而为患者提供更为精准、个性化的口服治疗方案。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/NzFhNTI4MGUwYzI0YmU3ZWQ0MDcxNDc2MTkyOTI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NzFhNTI4MGUwYzI0YmU3ZWQ0MDcxNDc2MTkyOTI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"303974","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","BK4585","LU0154236417.USD","NVOX","OZEM","PPH","BK4532","IE00BZ1G4Q59.USD","BK4007","BK4588","LU1093756325.SGD","BK4599","NVO","NVOH","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660446361","title":"诺和诺德(NVO.US)启动低剂量Wegovy口服药临床研究 瞄准更广泛减重人群","url":"https://stock-news.laohu8.com/highlight/detail?id=2660446361","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660446361?lang=zh_cn&edition=full","pubTime":"2026-08-19 16:50","pubTimestamp":1787129405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["THNR","BK4007","NVO","BK4585","IE00BKVL7J92.USD","BK4599","IE00BZ1G4Q59.USD","NVOH","PPH","NVOX","LU0154236417.USD","BK4588","LU1093756325.SGD","BK4532","LU1093756168.USD","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660448604","title":"据媒体消息，诺和诺德(NVO.US)在一项新的肥胖症研究中，开始测试低剂量Wegovy口服药片。","url":"https://stock-news.laohu8.com/highlight/detail?id=2660448604","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660448604?lang=zh_cn&edition=full","pubTime":"2026-08-19 15:31","pubTimestamp":1787124663,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["NVOX","BK4599","LU1093756325.SGD","THNR","BK4585","LU0154236417.USD","IE00BKVL7J92.USD","NVOH","BK4532","BK4007","NVO","PPH","IE00BZ1G4Q59.USD","BK4588","OZEM","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660149850","title":"美股异动｜减肥药概念股逆势上扬，礼来涨2.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660149850","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660149850?lang=zh_cn&edition=full","pubTime":"2026-08-18 21:54","pubTimestamp":1787061253,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0256863811.USD","IE00BFSS8Q28.SGD","LU1232071149.USD","LU2237443465.HKD","LU2462591350.SGD","LU1917777945.USD","BK4516","LU1093756168.USD","LU2108987350.USD","IE00BK4W5M84.HKD","LU0889565916.HKD","LU1366192091.USD","LU0820561909.HKD","LU1064131342.USD","LU1983299246.USD","LU1280957306.USD","IE0005OL40V9.USD","LU2089984988.USD","LU0417517546.SGD","LU0158827948.USD","LU1979441026.SGD","LU1127390331.HKD","LU2237443382.USD","LU2552382132.HKD","LU0316494557.USD","LU0353189680.USD","LU1069344957.HKD","LU2360106947.USD","LU0198837287.USD","SG9999017495.SGD","LU2471134952.CNY","LU1548497426.USD","LU0823434740.USD","LU1323610961.USD","LU1623119135.USD","LU2552382058.USD","MEDX","IE00BJT1NW94.SGD","RXL","LU2111349929.HKD","LU0471298777.SGD","LU0122379950.USD","LU0882574139.USD","LU0323591593.USD","LU2271345857.HKD","VHT","LU2456880835.USD","LU0456855351.SGD","LU1814569148.SGD","LU2023251221.USD","IE00BJJMRY28.SGD","LU0689472784.USD","LU2089284900.SGD","LU2168564065.EUR","LU0320765059.SGD","LU0210536198.USD","SGXZ31699556.SGD","LU0708995401.HKD","GB00BDT5M118.USD","LU0354030438.USD","LU0345770993.USD","LU0345770308.USD","LU1267930730.SGD","LU1629891620.HKD","LU2028103732.USD","LU2361044865.SGD","LU0943347566.SGD","LU1145028129.USD","LU0820562030.AUD","LU1868836914.USD","SG9999014880.SGD","IE00BKPKM429.USD","IE00BJJMRZ35.SGD","LU2461242641.AUD","LU0354030511.USD","LU1061106388.HKD","LU2213496289.HKD","LU2756315318.SGD","NVOX","LU2087625088.SGD","LU2237443549.SGD","IE00BKVL7J92.USD","LU0096364046.USD","XLV","LU0289739699.SGD","LU1291159041.SGD","MHIP","LU0683600562.USD","IE00B4R5TH58.HKD","IE00BZ1G4Q59.USD","IE00BFTCPJ56.SGD","LU0266013472.USD","LU0238689110.USD","LU1988902786.USD","LU2168564149.EUR","IE0004445239.USD","LU1057294990.SGD","ELIS","SG9999018865.SGD","SG9999014906.USD","LU0823434583.USD","LU0471298694.HKD","LU2063271972.USD","LU1974910355.USD","SG9999015978.USD","LU1712237335.SGD","HRTS","LU0154236417.USD","LU2471134879.HKD","LU1989771016.USD","THNR","LU2746668461.USD","LU0256863902.USD","IE00B1XK9C88.USD","LU0106261372.USD","LU0820561818.USD","LLYX","LU2237443895.HKD","IE00B2B36J28.USD","LU0640476718.USD","LU0882574055.USD","LU0058720904.USD","LU2491050154.USD","LU2750360641.GBP","LU2756315664.SGD","LU1868837136.USD","IE00BKDWB100.SGD","SG9999013999.USD","IE00BJLML261.HKD","LU1093756325.SGD","SG9999014914.USD","LU0061475181.USD","IHE","LU1035775433.USD","LU2168564222.USD","LLII","IE00B7KXQ091.USD","BK4533","IE00BN29S564.USD","LU2361044949.HKD","LU2357305700.SGD","IE00BWXC8680.SGD","LU2491049909.HKD","SG9999001176.SGD","IE00BJJMRX11.SGD","LU2552382215.SGD","LU2265009873.SGD","LLY","SGXZ57979304.SGD","LU2750360997.AUD","LU1868836757.USD","LU2236285917.USD","LU0225283273.USD","LU0823416689.USD","LU2491050071.SGD","PPH","LU0114720955.EUR","LU2168563687.JPY","LU2089283258.USD","LU2462157665.USD","TMED","LU2237443978.SGD","LU1023059063.AUD","LU1720051108.HKD","SG9999015952.SGD","OZEM","SG9999014898.SGD","LU0203201768.USD","LU0097036916.USD","LU0203202063.USD","LU0158827781.USD","IE0009355771.USD","BK4532","LU0094547139.USD","LU2471134796.USD","IE0004445015.USD","LU0964807845.USD","LU1868837300.USD","BK4585","BK4588","GDOC","LU1804176565.USD","LU2023250504.SGD","AGNG","LU2237443622.USD","IE00BK4W5L77.USD","LU2324357040.USD","LU2361045086.USD","NVOH","LU2106854487.HKD","FTXH","LU2168564495.EUR","LU0174119429.USD","LU2211815571.USD","SGXZ51526630.SGD","BK4007","LU0006306889.USD","CANC","LU2417539215.USD","ELIL","IXJ","LU2896262040.SGD","LU0786609619.USD","LU0432979614.USD","JDOC","IE00BFSS7M15.SGD","LU0079474960.USD","IE0002141913.USD","BK4534","LU0109391861.USD","LU0787776722.HKD","IE00B4JS1V06.HKD","LU2237438978.USD","BK4599","LU1868836591.USD","IE00B1BXHZ80.USD","LU0320765992.SGD","IE0001KFT4U8.USD","NVO","LU1720051017.SGD","SG9999001176.USD","LU1551013425.SGD","LU2468319806.SGD","BK4581","SG9999015986.USD","SGXZ81514606.USD","LU0672654240.SGD","IE00B775H168.HKD","LU1551013342.USD","LU0133085943.USD","LU2602419157.SGD","SGXZ99366536.SGD","LLYZ","LU0466842654.USD","LU0109394709.USD","LU2471134523.USD","LU0353189763.USD","LU0385154629.USD","ILDR","SG9999018857.SGD","SG9999015945.SGD","LU2112291526.USD","LU0234572021.USD","LU2023250330.USD","WDNA","LU2264538146.SGD","LU2746668974.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149711042","title":"异动解读｜诺和诺德盘中下跌3.05%，贝伦贝格下调评级至持有并降目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1149711042","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149711042?lang=zh_cn&edition=full","pubTime":"2026-08-12 21:48","pubTimestamp":1786542534,"startTime":"0","endTime":"0","summary":"8月12日，诺和诺德盘中下跌3.05%，报46.05美元/股，成交额8214.8万美元。消息面上，投行贝伦贝格将诺和诺德评级从\"买入\"下调至\"持有\"，同时将目标价从50美元下调至47美元。据FactSet统计，该股当前分析师平均评级为\"增持\"，平均目标价49.12美元。市场对诺和诺德GLP-1产品增长放缓及与礼来竞争压力加大的担忧持续发酵，叠加投行下调评级与目标价，进一步压制市场情绪。诺和诺德所在的制药行业中，礼来跌0.66%，默沙东涨0.74%，强生跌0.76%，辉瑞跌0.92%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"诺和诺德盘中下跌3.05%，贝伦贝格下调评级至持有并降目标价","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658319970","title":"贝伦贝格降诺和诺德评级至“持有”","url":"https://stock-news.laohu8.com/highlight/detail?id=2658319970","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658319970?lang=zh_cn&edition=full","pubTime":"2026-08-12 20:56","pubTimestamp":1786539374,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["THNR","BK4007","NVO","BK4585","IE00BKVL7J92.USD","BK4599","IE00BZ1G4Q59.USD","NVOH","PPH","NVOX","LU0154236417.USD","BK4588","LU1093756325.SGD","BK4532","LU1093756168.USD","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162996918","title":"异动解读｜诺和诺德盘前下跌3.05%，贝伦贝格下调目标价至47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1162996918","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162996918?lang=zh_cn&edition=full","pubTime":"2026-08-12 18:27","pubTimestamp":1786530424,"startTime":"0","endTime":"0","summary":"8月12日，诺和诺德盘前下跌3.05%，报45.73美元/股，成交额464.7万美元。消息面上，投行贝伦贝格将诺和诺德目标价从50美元下调至47美元，成为近期对该股发出谨慎信号的机构之一。市场对诺和诺德GLP-1产品增长放缓及与礼来竞争压力加大的担忧持续发酵，叠加投行下调目标价，进一步压制盘前情绪。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"诺和诺德盘前下跌3.05%，贝伦贝格下调目标价至47美元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658256429","title":"贝伦贝格将诺和诺德目标股价从50美元下调至47美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2658256429","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658256429?lang=zh_cn&edition=full","pubTime":"2026-08-12 13:05","pubTimestamp":1786511104,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","NVOH","THNR","OZEM","PPH","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4599","LU1093756168.USD","LU1093756325.SGD","NVOX","BK4585","BK4007","NVO","IE00BKVL7J92.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658199139","title":"礼来减重药片打响全球争夺战：Foundayo率先在欧洲获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2658199139","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658199139?lang=zh_cn&edition=full","pubTime":"2026-08-11 22:35","pubTimestamp":1786458904,"startTime":"0","endTime":"0","summary":"礼来的 Foundayo 获得英国监管批准，成为欧洲第二款 GLP-1 类减重口服药，也是该药物在欧洲大陆拿下的首个上市许可。Foundayo 初期仅可凭处方自费购买；能否纳入英国国民保健体系，有待成本效益评估结果。礼来在全球市场追赶诺和诺德的 Wegovy 口服制剂。 礼来减重药物 Foundayo 迎来欧洲首个上市批准，得以在英国市场与竞争对手诺和诺德的 Wegovy 口服药正面竞争。 礼来着重宣传：作为小分子药物，服用 Foundayo不存在饮食限制。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-11/doc-inimyhkf4128559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["BK4533","LU1974910355.USD","LU0354030438.USD","LU0289739699.SGD","MHIP","LU2471134879.HKD","AGNG","LU2471134796.USD","LU0943347566.SGD","IXJ","LU1804176565.USD","LU2471134523.USD","LU0006306889.USD","LU0889565916.HKD","LU0158827781.USD","LU0225283273.USD","LU2111349929.HKD","LU2108987350.USD","LU2456880835.USD","LU0109391861.USD","LU2089283258.USD","LU2750360641.GBP","SG9999014906.USD","LU0133085943.USD","SG9999017495.SGD","LU1291159041.SGD","LU2271345857.HKD","LU2360106947.USD","LU1868836757.USD","MEDX","LU0316494557.USD","THNR","SG9999015952.SGD","LU1551013425.SGD","LU0345770993.USD","IE0005OL40V9.USD","OZEM","SGXZ57979304.SGD","NVOH","LU1629891620.HKD","IE00B1XK9C88.USD","HRTS","LU2236285917.USD","LU2106854487.HKD","LU0323591593.USD","LU1720051108.HKD","LU0471298777.SGD","LU0820562030.AUD","IE00BJJMRX11.SGD","LU0122379950.USD","LU2237443622.USD","LU2756315664.SGD","IE00BN29S564.USD","IE00BJJMRY28.SGD","LU1868836914.USD","SG9999014880.SGD","LU2089284900.SGD","LU0823434583.USD","GDOC","FHLC","NVO","LU1366192091.USD","IE00BKDWB100.SGD","SG9999018857.SGD","BK4534","ILDR","BK4599","LU0096364046.USD","LU2265009873.SGD","SG9999015978.USD","LU0198837287.USD","FTXH","LLII","LU1023059063.AUD","LU0158827948.USD","LU2324357040.USD","LU0058720904.USD","LU0432979614.USD","LU2491049909.HKD","SGXZ31699556.SGD","IYH","LU0174119429.USD","IE00BFSS7M15.SGD","LU2168564065.EUR","LU0820561909.HKD","LU1988902786.USD","LU1623119135.USD","LU2168563687.JPY","LU0353189763.USD","LU0109394709.USD","BK4516","LU2461242641.AUD","BK4581","IE0004445015.USD","LU2023250504.SGD","LU0471298694.HKD","LU0823434740.USD","LU1093756325.SGD","LU0823416689.USD","LU0882574139.USD","SG9999014898.SGD","IE00B775H168.HKD","LU1145028129.USD","LU2756315318.SGD","LU0154236417.USD","LU0385154629.USD","IE00BFTCPJ56.SGD","LU2063271972.USD","IE0002141913.USD","LU0708995401.HKD","LU2237443382.USD","LU0256863902.USD","IE00BK4W5M84.HKD","LU0094547139.USD","LU1712237335.SGD","LU2023250330.USD","LU1551013342.USD","SG9999018865.SGD","LU2089984988.USD","CANC","LU1093756168.USD","TRUH","TMED","SG9999013999.USD","LU2746668974.SGD","LLYZ","LU1280957306.USD","LU1064131342.USD","LU0079474960.USD","LU2361045086.USD","IE00B4JS1V06.HKD","IE00BJT1NW94.SGD","LU0882574055.USD","LU0683600562.USD","LU0256863811.USD","SGXZ51526630.SGD","SG9999014914.USD","IE00B4R5TH58.HKD","LU2491050071.SGD","LU0786609619.USD","LU1983299246.USD","LU0114720955.EUR","LU1868837136.USD","LU0345770308.USD","LU2112291526.USD","IE00BKPKM429.USD","LU2361044865.SGD","LU0203202063.USD","IE0004445239.USD","ELIL","LU2468319806.SGD","LU2896262040.SGD","LU0266013472.USD","LLY","LU1267930730.SGD","LU2491050154.USD","LU0672654240.SGD","LU0417517546.SGD","LU1814569148.SGD","LU1323610961.USD","LU2211815571.USD","LU2552382215.SGD","LU0354030511.USD","LU2237443978.SGD","IE00BJJMRZ35.SGD","LU0320765059.SGD","NVOX","LU0203201768.USD","LU2471134952.CNY","LU1868837300.USD","LU2237438978.USD","LU2264538146.SGD","IE00BJLML261.HKD","LU2237443549.SGD","ELIS","LU2168564495.EUR","VHT","LU2602419157.SGD","LU0456855351.SGD","IE00BFSS8Q28.SGD","LU0238689110.USD","LU0106261372.USD","LU2168564222.USD","LU1035775433.USD","LU2028103732.USD","IE00B1BXHZ80.USD","LU2357305700.SGD","LU2213496289.HKD","LU2462157665.USD","LU2023251221.USD","IHE","BK4585","LU0640476718.USD","LU0964807845.USD","LU1232071149.USD","LU2087625088.SGD","LU2462591350.SGD","SG9999001176.SGD","LU1127390331.HKD","IE0009355771.USD","LU1720051017.SGD","LU1548497426.USD","LU2168564149.EUR","LU2361044949.HKD","PPH","IE00B7KXQ091.USD","MEDI","WDNA","LU1989771016.USD","IE00BZ1G4Q59.USD","LU2746668461.USD","LU1917777945.USD","LU0061475181.USD","SGXZ81514606.USD","LU1979441026.SGD","LU2417539215.USD","LU2750360997.AUD","JDOC","BK4007","IE00BWXC8680.SGD","SG9999001176.USD","LLYX","GB00BDT5M118.USD","BK4532","IE0001KFT4U8.USD","IE00B2B36J28.USD","LU0353189680.USD","LU0234572021.USD","LU2552382132.HKD","PJP","IE00BKVL7J92.USD","LU1057294990.SGD","LU1069344957.HKD","RXL","IE00BK4W5L77.USD","LU1868836591.USD","LU2237443895.HKD","LU0787776722.HKD","LU2237443465.HKD","LU2552382058.USD","SG9999015945.SGD","SG9999015986.USD","SGXZ99366536.SGD","BK4588","LU0210536198.USD","LU0689472784.USD","LU0320765992.SGD","LU0097036916.USD","LU0820561818.USD","XLV","CURE","LU0466842654.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658765961","title":"礼来替尔泊肽狂飙：上半年销售277亿美元，GLP-1赛道格局重塑","url":"https://stock-news.laohu8.com/highlight/detail?id=2658765961","media":"蓝鲸财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658765961?lang=zh_cn&edition=full","pubTime":"2026-08-11 13:06","pubTimestamp":1786424797,"startTime":"0","endTime":"0","summary":"作者｜全球财说 王云礼来替尔泊肽上半年销售额达到277亿美元，逼近单一药物销售天花板，机构基于上半年表现测算，该产品全年营收有望冲击550-600亿美元，触碰全球药物销售的历史天花板。礼来上调2026全年营收指引，公司市值向5000亿美元迈进，GLP-1赛道“一超多强”格局正在加速成型。产品层面，替尔泊肽作为GLP-1/GIP双受体激动剂，同时覆盖2型糖尿病与肥胖两大适应症，减重疗效优于传统单靶点GLP-1制剂。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1786075003110402816","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU0466842654.USD","RXL","SGXZ99366536.SGD","IE00BJLML261.HKD","LU0094547139.USD","LU0079474960.USD","LU0354030438.USD","LU0385154629.USD","LU2471134879.HKD","IXJ","LU0417517546.SGD","THNR","IE00B1XK9C88.USD","IE0001KFT4U8.USD","WDNA","LU2417539215.USD","LU1127390331.HKD","LU1814569148.SGD","LU0889565916.HKD","LU1145028129.USD","LU1551013342.USD","IE00BJJMRZ35.SGD","LU2491049909.HKD","LU0683600562.USD","AGNG","LU2023250504.SGD","LU2108987350.USD","LU2213496289.HKD","VHT","LU0122379950.USD","LU0823434583.USD","LU1366192091.USD","LU2237443549.SGD","BK4588","IE00BKDWB100.SGD","LU2491050154.USD","LU2360106947.USD","LU1064131342.USD","LU0133085943.USD","ELIS","LU0820561818.USD","LU0109394709.USD","LU1720051108.HKD","LU0203201768.USD","LU2552382215.SGD","LU2552382132.HKD","LU1023059063.AUD","IHE","LU1093756168.USD","LU2756315664.SGD","IYH","LU2468319806.SGD","IE00B1BXHZ80.USD","LU1988902786.USD","LU2063271972.USD","MEDX","IE00B2B36J28.USD","BK4532","LU0096364046.USD","LU1629891620.HKD","LU2023251221.USD","SGXZ51526630.SGD","LU0820561909.HKD","LU0106261372.USD","LU2361044865.SGD","IE00B4R5TH58.HKD","LU0689472784.USD","LU2896262040.SGD","TRUH","LU2471134952.CNY","LU2602419157.SGD","IE00BWXC8680.SGD","LLY","LU0234572021.USD","TMED","IE00BK4W5L77.USD","IE00BKPKM429.USD","LU1868836914.USD","IE00BFSS7M15.SGD","LU2089284900.SGD","LU2028103732.USD","LU2237443978.SGD","SG9999014880.SGD","ELIL","LU1974910355.USD","LU2750360641.GBP","LU2264538146.SGD","LU2471134523.USD","LU0256863811.USD","LU2552382058.USD","LU0786609619.USD","LU1989771016.USD","SG9999015945.SGD","LU2756315318.SGD","LU2357305700.SGD","LU1035775433.USD","LU1069344957.HKD","LU0266013472.USD","IE00B7KXQ091.USD","LU1551013425.SGD","LU2089984988.USD","IE00B4JS1V06.HKD","LU2462157665.USD","LU0943347566.SGD","LU1323610961.USD","LU0353189763.USD","SG9999018865.SGD","NVOH","LU0114720955.EUR","MEDI","SG9999017495.SGD","LU0006306889.USD","CANC","IE0004445015.USD","LU0238689110.USD","CURE","LU0097036916.USD","LU0210536198.USD","LU0471298777.SGD","LU0882574139.USD","LU1623119135.USD","LU0672654240.SGD","LU1868837300.USD","LU2456880835.USD","LU0640476718.USD","IE00BFSS8Q28.SGD","SG9999015986.USD","LU2237443622.USD","LU0256863902.USD","LU1267930730.SGD","LU0345770993.USD","SG9999015952.SGD","SGXZ57979304.SGD","IE00B775H168.HKD","GDOC","MHIP","LU0058720904.USD","LU2237443382.USD","LU1232071149.USD","LU0158827781.USD","LU2211815571.USD","LU2106854487.HKD","LU0203202063.USD","LU1548497426.USD","LU2746668461.USD","LU2750360997.AUD","NVOX","XLV","LU2361044949.HKD","PPH","NVO","LU0882574055.USD","LU2237438978.USD","SG9999013999.USD","LU2168564495.EUR","IE00BKVL7J92.USD","LU1917777945.USD","LU1291159041.SGD","BK4534","IE0004445239.USD","LU1712237335.SGD","LU0316494557.USD","SG9999014906.USD","LU1093756325.SGD","FHLC","LLYZ","BK4516","LU0109391861.USD","IE0005OL40V9.USD","LU0456855351.SGD","LU0353189680.USD","LU0289739699.SGD","LU2168564222.USD","SG9999001176.SGD","IE00BZ1G4Q59.USD","LU2236285917.USD","LU2237443895.HKD","LU0323591593.USD","LU2168563687.JPY","LU1720051017.SGD","LU0823434740.USD","SG9999014898.SGD","BK4599","SG9999014914.USD","LU0320765059.SGD","SG9999015978.USD","LU2491050071.SGD","LU1983299246.USD","LU2112291526.USD","LLII","IE0002141913.USD","LU0320765992.SGD","LU0471298694.HKD","BK4585","SG9999001176.USD","IE00BN29S564.USD","LU0354030511.USD","LU2087625088.SGD","LU2461242641.AUD","LU0158827948.USD","LU1868836757.USD","LU0198837287.USD","LU2111349929.HKD","LU0823416689.USD","PJP","LU1061106388.HKD","ILDR","LU0061475181.USD","LU2324357040.USD","LU1280957306.USD","LU0154236417.USD","SGXZ81514606.USD","LU1979441026.SGD","LU0345770308.USD","SGXZ31699556.SGD","IE00BJT1NW94.SGD","LU2168564065.EUR","IE00BJJMRY28.SGD","LU2462591350.SGD","LU0787776722.HKD","LU0432979614.USD","LU2471134796.USD","SG9999018857.SGD","LLYX","LU0174119429.USD","LU1804176565.USD","LU2271345857.HKD","LU2237443465.HKD","FTXH","IE00BJJMRX11.SGD","HRTS","IE0009355771.USD","LU0225283273.USD","LU0708995401.HKD","BK4533","LU2361045086.USD","LU2089283258.USD","LU2023250330.USD","LU1868837136.USD","LU2746668974.SGD","BK4581","OZEM","LU0964807845.USD","LU1057294990.SGD","LU1868836591.USD","BK4007","GB00BDT5M118.USD","LU0820562030.AUD","IE00BFTCPJ56.SGD","LU2168564149.EUR","LU2265009873.SGD","IE00BK4W5M84.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658939381","title":"诺和诺德与亚马逊AWS建立战略合作伙伴关系 推动通过人工智能加速药物研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2658939381","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658939381?lang=zh_cn&edition=full","pubTime":"2026-08-10 20:39","pubTimestamp":1786365584,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["AMZZ","QQA","TARK","TECY","DQJN","IBBJ","PPH","PBOT","AMZU","AMZN","THNR","NBDS","NEWZ","AIFD","QID","AMZY","ARTY","BGIA","LCLG","NVOX","CLIX","AIQU","WANT","WPAI","ONLN","MVPS","ILDR","KOMP","AGIX","FWD","NVOH","OGIG","AMZP","MFIG","GK","USAW.SI","HULL","AQGX","CWC","AZYY","AIBU","CPNQ","QTOC","VUSE","AMZD","NVO","OZEM","CHAT","QSWN","RTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658366319","title":"亚马逊公司：诺和诺德选定 AWS 作为合作伙伴。","url":"https://stock-news.laohu8.com/highlight/detail?id=2658366319","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658366319?lang=zh_cn&edition=full","pubTime":"2026-08-10 20:14","pubTimestamp":1786364088,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BJJMRY28.SGD","IE00BMPRXQ63.HKD","LU1316542783.SGD","LU0689472784.USD","LU1069344957.HKD","LU1718418525.SGD","LU2168564222.USD","LU0985320562.USD","LU2505996681.GBP","LU1145028129.USD","AMZY","LU1861558580.USD","SG9999000418.SGD","LU2750360641.GBP","AMZN","LU0323591593.USD","LU0211328371.USD","LU0354030511.USD","BK4599","IE00BQXX3D17.EUR","LU0820562030.AUD","LU2720916845.USD","LU0354030438.USD","LU1323610961.USD","SGXZ81514606.USD","LU2065170008.USD","LU0210533765.USD","IE00B19Z9505.USD","LU1366192091.USD","BK4527","LU2420271590.USD","LU0820561909.HKD","LU2750360997.AUD","IE00BJTD4N35.SGD","IE0009356076.USD","LU0784383803.USD","BK4524","THNR","LU1119994496.HKD","LU1803068979.SGD","LU2237957811.SGD","LU2275660780.HKD","LU0154236417.USD","LU2087625088.SGD","LU0345770308.USD","SGXZ44715902.SGD","LU1791710582.SGD","LU2462157665.USD","LU0965509101.SGD","LU2896262040.SGD","LU0648000940.SGD","OZEM","LU0097036916.USD","LU2083900584.USD","LU0786609619.USD","IE00BQXX3F31.USD","LU0061474705.USD","LU0251131958.USD","LU1914381329.SGD","LU0528227936.USD","LU0128525929.USD","LU2092937148.SGD","LU0158827948.USD","LU0820561818.USD","BK4559","LU1066051225.USD","LU0096362180.USD","LU0149725797.USD","LU1720051108.HKD","LU0823411888.USD","LU0312595415.SGD","LU2461242641.AUD","IE00B5949003.HKD","BK4535","LU0964807845.USD","LU0162691827.USD","IE00BFXG0V08.USD","LU0494093205.USD","LU1839511570.USD","IE00B19Z3B42.SGD","ILDR","SG9999004303.SGD","LU0345768153.USD","LU0640476718.USD","AMZU","LU1935042488.USD","LU1066051498.USD","LU2543165471.USD","IE00B3S45H60.SGD","LU0345769631.USD","BK4579","LU0949170426.SGD","LU0345774631.USD","LU2168564149.EUR","LU1301847155.USD","BK4220","LU1235294995.USD","LU1974910355.USD","LU0310799852.SGD","AMZP","LU1691799644.USD","LU2505996509.AUD","LU1917777945.USD","BK4604","IE000SO60NU8.SGD","LU2326559502.SGD","LU0823421416.USD","IE00B1BXHZ80.USD","LU0210536198.USD","LU2592432038.USD","RTH","SGXZ80539844.SGD","LU2242649171.HKD","LU2487616109.SGD","LU0345770993.USD","IE000WAW04H5.SGD","SG9999002224.SGD","LU0048584097.USD","GB00BDT5M118.USD","SGXZ99366536.SGD","LU1046421795.USD","IE00B19Z8X17.USD","LU1880398554.USD","LU2860962120.EUR","IE000M9KFDE8.USD","LU2092627202.USD","LU1127390331.HKD","BK4122","BK4554","LU1979441026.SGD","IE00BZ1G4Q59.USD","LU0308772762.SGD","LU1935042991.SGD","SG9999015945.SGD","LU0316494557.USD","LU0943347566.SGD","LU2362541513.USD","LU1201861165.SGD","LU0234570918.USD","LU0823434740.USD","LU2317271919.USD","LU0345768740.USD","LU0980610538.SGD","IE00BYQQ9H92.USD","LU0320765059.SGD","LU0965508806.USD","IE0004445239.USD","LU2087621335.USD","IE00B19Z8W00.USD","LU2077746001.SGD","LU0787776722.HKD","LU2023250330.USD","LU2954938101.SGD","LU0072462426.USD","LU1116320737.USD","IE000W1ABFV2.USD","LU2023250843.SGD","LU2361044949.HKD","LU0157215616.USD","IE0004091025.USD","IE00BN29S564.USD","LU2602419157.SGD","HK0000304805.HKD","LU1267930490.SGD","LU0130102774.USD","BK4507","LU2764263039.SGD","LU0174119429.USD","LU0029864427.USD","CLIX","LU2264538146.SGD","LU1232071149.USD","LU0127658192.USD","LU0203201768.USD","LU1201861249.SGD","LU0238689110.USD","IE000ITXATA3.USD","LU2237957902.USD","LU1551013425.SGD","LU0048573561.USD","LU2106854487.HKD","LU0784385840.USD","LU1934455194.USD","BK4550","IE0003U64NQ7.SGD","IE0034235303.USD","LU2108987350.USD","LU1720051017.SGD","LU2357305700.SGD","LU1823568750.SGD","LU0724617625.USD","IE0001KFT4U8.USD","LU2361045086.USD","LU0784385170.HKD","BK4533","SG9999014914.USD","LU0882574139.USD","LU1496350171.SGD","LU2756315664.SGD","IE00BFSS8Q28.SGD","LU1861127337.USD","IE00BKDWB100.SGD","IE0002270589.USD","LU1064131342.USD","LU0320765489.SGD","LU2247934214.USD","LU0109392836.USD","LU0742534661.SGD","LU1244550577.SGD","LU0256863811.USD","IE00BK4W5M84.HKD","LU0672654240.SGD","LU1267930573.SGD","LU0353189763.USD","IE00B775H168.HKD","NVOH","LU1267930730.SGD","LU0708994859.HKD","IE00BJTD4V19.USD","IE00B7SZLL34.SGD","LU1435385759.SGD","LU1868837300.USD","LU1280957306.USD","LU2381873111.SGD","HK0000914660.USD","LU0251142724.SGD","LU2756315318.SGD","HK0000304797.USD","NVO","LU2746668461.USD","BK4588","LU0053666078.USD","BK4596","LU0158827781.USD","IE00BK4W5L77.USD","BK4503","LU1989764748.USD","LU0082616367.USD","LU1791710400.SGD","LU2065169927.USD","LU2271345857.HKD","AMZZ","BK4543","IE0004086264.USD","SGXZ23171101.USD","LU0642271901.SGD","LU0208291251.USD","LU1868836591.USD","LU2463028550.USD","SG9999014906.USD","LU1551013342.USD","LU0823421333.USD","LU0061475181.USD","LU1244550494.USD","IE00BKPKM429.USD","LU1880398471.USD","LU2361044865.SGD","LU1035775433.USD","LU0289960550.SGD","IE00B775SV38.USD","LU1852331112.SGD","LU1116320901.HKD","LU0871640123.AUD","AZYY","SG9999017495.SGD","BK4551","LU2552382132.HKD","LU2471134523.USD","LU2125154935.USD","LU0348723411.USD","LU0077335932.USD","LU2023250504.SGD","LU2023251221.USD","LU1244550221.USD","BK4561","LU0276348264.USD","IE00B7KXQ091.USD","HK0000914686.HKD","LU0079474960.USD","LU1066051811.HKD","LU2097829019.USD","SG9999002232.USD","LU0203202063.USD","LU0198837287.USD","LU0957791311.USD","LU2362541273.HKD","LU2236285917.USD","IE00BMPRXR70.SGD","SG9999014898.SGD","LU1674673428.USD","LU0211327993.USD","IE00BWXC8680.SGD","LU2360032135.SGD","LU0265550359.USD","LU0861579265.USD","LU2054465674.USD","LU0130103400.USD","LU2637965513.SGD","IE0004445015.USD","LU1934455277.USD","LU0314104364.USD","SGXZ51526630.SGD","LU2089284900.SGD","BK4548","LU1868836914.USD","LU0390134368.USD","LU2471134879.HKD","LU0109391861.USD","LU0107464264.USD","SG9999001077.SGD","IE000MB6IJN5.SGD","LU1366333091.USD","LU2764263203.CNY","LU1093756168.USD","LU1633808545.USD","LU1084165304.USD","LU2999663052.SGD","LU1988902786.USD","LU1815333072.USD","ONLN","BK4532","SG9999018865.SGD","LU0070217475.USD","LU0708995401.HKD","LU0466842654.USD","LU2746668974.SGD","IE00B3SWFQ91.USD","IE00BQXX3C00.GBP","LU2211815571.USD","LU0345774391.USD","IE00BKVL7J92.USD","SG9999014880.SGD","LU0256863902.USD","IE00BJJMRX11.SGD","LU0788109477.HKD","LU2063271972.USD","BK4598","LU1868836757.USD","SG9999018857.SGD","IE00BFSS7M15.SGD","LU2462591277.SGD","BK4007","BK4534","LU1037948897.HKD","LU1548497426.USD","AMZD","LU2430703178.SGD","IE0009G5SDU7.USD","LU2065171402.SGD","IE0005OL40V9.USD","LU1037948541.HKD","LU2265009873.SGD","LU1074936037.SGD","LU2242650005.HKD","LU0210528500.USD","LU2471134952.CNY","LU2211817866.USD","LU0143551892.USD","HK0000532082.HKD","LU2089283258.USD","LU2362540622.SGD","LU2764262908.HKD","LU0784384876.USD","IE00B19Z3581.USD","LU2552382058.USD","LU1629891620.HKD","IE000KEQY171.SGD","IE00B5TLWC47.USD","LU0719512351.SGD","BK4592","AMZW","LU0072461881.USD","LU0417517546.SGD","LU0289941410.SGD","LU1935042215.USD","IE0000B7K699.USD","IE00B4JS1V06.HKD","LU0683600562.USD","PPH","LU1429558221.USD","LU0965509010.AUD","LU1804176565.USD","IE000F7OJYX1.SGD","IE00B4YYXB79.USD","LU2417539215.USD","LU2125154778.USD","IE000BZT7R73.USD","LU0456855351.SGD","LU0889565833.HKD","LU1093756325.SGD","LU1066053197.SGD","BK4612","LU2430703251.USD","LU0345769128.USD","LU2237438978.USD","LU2456880835.USD","LU2403377893.USD","LU0234572021.USD","LU0096364046.USD","LU0175139822.USD","SG9999015952.SGD","LU2065171311.SGD","LU0353189680.USD","LU1261432733.SGD","LU2168564065.EUR","WANT","LU2360106780.USD","LU0061474960.USD","LU1778281490.HKD","IE00BJLML261.HKD","LU2168564495.EUR","LU2552382215.SGD","LU0823434583.USD","LU1868837136.USD","LU1935043023.USD","BK4581","LU2213496289.HKD","BK4538","LU0648001328.SGD","BK4566","LU0080751232.USD","LU1934455863.HKD","SGXZ31699556.SGD","LU0302445910.USD","NVOX","LU1935043536.SGD","LU1674673691.USD","LU1883839398.USD","LU0011850046.USD","LU2430703095.HKD","AMZG","IE000YTNTUN2.SGD","LU1989764664.SGD","LU2452424414.USD","LU0133085943.USD","LU0056508442.USD","LU2250418816.HKD","IE00BMPRXN33.USD","LU0070302665.USD","LU2168563687.JPY","USAW.SI","HULL","LU2462591350.SGD","LU0965509283.SGD","IE00B1XK9C88.USD","BK4585","LU0170899867.USD","LU0342679015.USD","LU2111349929.HKD","LU0267386448.USD","LU1496350502.SGD","SG9999015986.USD","LU0310800379.SGD","LU0251132253.USD","LU1814569148.SGD","LU1153585028.USD","LU1861559042.SGD","LU2471134796.USD","OGIG","LU2028103732.USD","SG9999015978.USD","LU0215105999.USD","LU0138981039.USD","LU0265550946.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658711935","title":"诺和诺德(NVO.US)：各方人士在伦敦共同打造了一个创新中心。该合作将利用人工智能作为诺和诺德的创新驱动力。","url":"https://stock-news.laohu8.com/highlight/detail?id=2658711935","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658711935?lang=zh_cn&edition=full","pubTime":"2026-08-10 20:04","pubTimestamp":1786363475,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4532","BK4585","NVOX","BK4007","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1093756168.USD","NVOH","LU1093756325.SGD","PPH","THNR","BK4588","OZEM","BK4599","LU0154236417.USD","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658986903","title":"伯恩斯坦将诺和诺德目标价从200丹麦克朗上调至203丹麦克朗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2658986903","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658986903?lang=zh_cn&edition=full","pubTime":"2026-08-10 15:57","pubTimestamp":1786348653,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4532","IE00BKVL7J92.USD","BK4007","NVO","IE00BZ1G4Q59.USD","BK4599","LU0154236417.USD","OZEM","BK4585","BK4588","NVOX","NVOH","LU1093756168.USD","THNR","LU1093756325.SGD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181955205","title":"Scholar Rock 因FDA质控警告，将诺和诺德工厂从药物申请中剔除","url":"https://stock-news.laohu8.com/highlight/detail?id=1181955205","media":"投资观察","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181955205?lang=zh_cn&edition=full","pubTime":"2026-08-08 04:51","pubTimestamp":1786135897,"startTime":"0","endTime":"0","summary":"Scholar Rock Holding 正从其用于治疗脊髓性肌萎缩症的 apitegromab 生物制剂许可申请中，移除一座由诺和诺德拥有的灌装-封装设施。此举背景是，该设施因可能面临美国食品药品监督管理局的执法行动而被标记。Scholar Rock 透露，公司于周五收到客户通知，称FDA已将首个灌装-封装设施——即诺和诺德旗下的Catalent Indiana——在4月的一次现场检查后，归类为“官方行动指示”。“Scholar Rock 将继续与FDA密切合作，并遵循其指导，将Catalent Indiana从apitegromab的BLA中移除，”公司表示。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BKVL7J92.USD","LU0154236417.USD","BK4588","NVOH","LU1093756325.SGD","BK4007","IBRN","PPH","SRRK","BK4599","OZEM","IE00BZ1G4Q59.USD","BK4532","LU1093756168.USD","NVOX","NVO","THNR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180906241","title":"异动解读｜诺和诺德盘中上涨3.15%，Q2财报超预期叠加荷兰专利胜诉持续提振市场情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1180906241","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180906241?lang=zh_cn&edition=full","pubTime":"2026-08-07 21:44","pubTimestamp":1786110289,"startTime":"0","endTime":"0","summary":"8月7日，诺和诺德盘中上涨3.15%，报46.92美元/股，成交额8089.98万美元。此外，荷兰海牙地区法院裁定Ceban公司复方司美格鲁肽鼻喷雾剂侵犯诺和诺德专利权并下达临时禁令，进一步巩固其GLP-1核心资产知识产权壁垒。此前公司因心脏新药ziltivekimab三期试验失败股价曾暴跌近10%，当前连续反弹反映市场对核心GLP-1业务韧性及专利保护力度的重新定价。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"诺和诺德盘中上涨3.15%，Q2财报超预期叠加荷兰专利胜诉持续提振市场情绪","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171603755","title":"异动解读｜诺和诺德盘前上涨3.09%，Q2财报超预期叠加荷兰专利胜诉持续提振市场情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1171603755","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171603755?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:12","pubTimestamp":1786090359,"startTime":"0","endTime":"0","summary":"8月7日，诺和诺德盘前上涨3.09%，报47.39美元/股，成交额232.58万美元。此外，荷兰海牙地区法院裁定Ceban公司复方司美格鲁肽鼻喷雾剂侵犯诺和诺德专利权并下达临时禁令，进一步巩固其GLP-1核心资产知识产权壁垒。此前公司因心脏新药ziltivekimab三期试验失败股价曾暴跌近10%，当前连续反弹反映市场对核心GLP-1业务韧性及专利保护力度的重新定价。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"诺和诺德盘前上涨3.09%，Q2财报超预期叠加荷兰专利胜诉持续提振市场情绪","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657690414","title":"丹麦制药商诺和诺德、西兰制药早盘交易上涨3%至4%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657690414","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657690414?lang=zh_cn&edition=full","pubTime":"2026-08-07 15:14","pubTimestamp":1786086882,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVOX","BK4588","LU0154236417.USD","OZEM","IE00BKVL7J92.USD","PPH","LU1093756325.SGD","NVOH","NVO","LU1093756168.USD","BK4532","THNR","BK4007","BK4599","IE00BZ1G4Q59.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177400893","title":"异动解读｜诺和诺德盘中上涨3.02%，Q2财报超预期叠加荷兰专利胜诉持续提振市场情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1177400893","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177400893?lang=zh_cn&edition=full","pubTime":"2026-08-07 03:04","pubTimestamp":1786043085,"startTime":"0","endTime":"0","summary":"8月7日，诺和诺德盘中上涨3.02%，报45.86美元/股，成交额4.19亿美元。此外，荷兰海牙地区法院裁定Ceban公司复方司美格鲁肽鼻喷雾剂侵犯诺和诺德专利权并下达临时禁令，进一步巩固其GLP-1核心资产的知识产权壁垒。此前公司因心脏新药ziltivekimab三期试验失败股价曾暴跌近10%，当前连续反弹反映市场对核心GLP-1业务韧性及专利保护力度的重新定价。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.novonordisk.com","stockEarnings":[{"period":"1week","weight":0.0185},{"period":"1month","weight":-0.0301},{"period":"3month","weight":0.0396},{"period":"6month","weight":-0.0143},{"period":"1year","weight":-0.1571},{"period":"ytd","weight":-0.0814}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Novo Nordisk A/S成立于1989年，由两家丹麦公司Nordisk Gentofte A/S和Novo Industri A/S合并而成。该公司是一家全球性的医疗保健公司，也是肥胖和糖尿病护理、制造和营销包括GLP-1受体激动剂和现代胰岛素在内的医药产品的世界领先企业。总部位于丹麦，业务遍及约80个国家，产品销往约170个国家。","yearOnYearQuotes":[{"month":1,"riseRate":0.533333,"avgChangeRate":0.120105},{"month":2,"riseRate":0.6,"avgChangeRate":0.019219},{"month":3,"riseRate":0.444444,"avgChangeRate":0.006415},{"month":4,"riseRate":0.622222,"avgChangeRate":0.018023},{"month":5,"riseRate":0.565217,"avgChangeRate":0.019713},{"month":6,"riseRate":0.695652,"avgChangeRate":0.026728},{"month":7,"riseRate":0.478261,"avgChangeRate":-0.002045},{"month":8,"riseRate":0.521739,"avgChangeRate":0.005855},{"month":9,"riseRate":0.555556,"avgChangeRate":-0.002979},{"month":10,"riseRate":0.488889,"avgChangeRate":-0.004606},{"month":11,"riseRate":0.6,"avgChangeRate":0.026574},{"month":12,"riseRate":0.733333,"avgChangeRate":0.048757}],"exchange":"NYSE","name":"诺和诺德","nameEN":"Novo-Nordisk A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺和诺德(NVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺和诺德,NVO,诺和诺德股票,诺和诺德股票老虎,诺和诺德股票老虎国际,诺和诺德行情,诺和诺德股票行情,诺和诺德股价,诺和诺德股市,诺和诺德股票价格,诺和诺德股票交易,诺和诺德股票购买,诺和诺德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺和诺德(NVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}